LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | A443654 | 1.0012 |
| BT-20 | Afatinib | 0.2554 |
| BT-20 | AT-7519 | 0.8635 |
| BT-20 | AZD 5438 | 0.7481 |
| BT-20 | AZD-6482 | 0.4268 |
| BT-20 | AZD7762 | 0.5818 |
| BT-20 | AZD8055 | 0.9221 |
| BT-20 | AZD8330 | 0.2496 |
| BT-20 | Barasertib | 0.6415 |
| BT-20 | Dactolisib | 0.8940 |
| BT-20 | BI-2536 | 1.1531 |
| BT-20 | SNS-032 | 1.0851 |
| BT-20 | BMS345541 | 0.1828 |
| BT-20 | Brivanib | 0.0790 |
| BT-20 | Buparlisib | 0.7008 |
| BT-20 | BX-912 | 0.1462 |
| BT-20 | Alpelisib | 0.4342 |
| BT-20 | Canertinib | 0.2763 |
| BT-20 | Celastrol | 0.5273 |
| BT-20 | CGP60474 | 1.2140 |
| BT-20 | CHIR-99021 | 0.0328 |
| BT-20 | CP466722 | 0.0302 |
| BT-20 | CP724714 | 0.1785 |
| BT-20 | Crizotinib | 0.3437 |
| BT-20 | Seliciclib | 0.1755 |